Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
> Pharma China Web Edition
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
News
12/2/2024
UCB Closes Divestment from Neurology and Allergy Portfolio in China, ...
12/2/2024
Allink Biotherapeutics Secures $42M Series A to Advance Oncology and I...
12/2/2024
Hangzhou Jiuyuan Gene Engineering Debuts on Hong Kong Stock Exchange
12/2/2024
Merck's Recarbrio Approved in China for Severe Bacterial Pneumonia
12/2/2024
Minghui Pharma Reports Positive Phase III Results for MH004 in Atopic ...
12/2/2024
Shanghai Cell Therapy Group Submits Application Proof for Hong Kong Li...
12/2/2024
Affinity Biopharma Raises Over CNY 400M in Series B2 to Advance Tumor-...
12/2/2024
Zambon's Xadago (Safinamide) Gains Chinese Approval for Parkinson's Di...
12/2/2024
Nanjing Leads Biolabs Files for Hong Kong IPO
12/2/2024
Miracogen to Present Phase II Data on MRG003 at ESMO Asia 2024
12/2/2024
Hua Medicine Announces Successful H.K. SENSITIZE Study Results at the ...
12/2/2024
Everest Medicines Announces Acceptance of VELSIPITY NDA in Hong Kong
11/29/2024
Recent Executive Moves
11/28/2024
AstraZeneca's Enhertu Secures Reimbursement Listing Despite Ongoing Pr...
11/28/2024
BeOne Secures EU Approval for First-Line Checkpoint Blocker
11/28/2024
NMPA Solicits Public Comments on the Provisions for the Record Filing ...
11/28/2024
NHSA and MOHRSS Announce the 2024 National Drug Reimbursement List
11/28/2024
NHSA Issues Guidelines for Managing Pricing Risks of Shortage Drugs
11/27/2024
China Introduces New Policy to Strengthen Hierarchical Medical Care an...
11/27/2024
NHSA: Policies in Development to Synchronize Medical Insurance Funds a...
11/27/2024
Policy Change Set to Advance Cell and Gene Therapy in China
11/27/2024
CMS's CMS-D005 Gets Green Light for Its Obesity Drug Trials in China
11/27/2024
NMPA Accepts Akeso's sNDA for Penpulimab Plus Anlotinib for Advanced H...
11/27/2024
Hengrui Initiates Clinical Trial for SHR-1826, a c-Met ADC Drug
11/27/2024
Kelun's Merck-partnered TROP2 ADC sac-TMT Approved for Marketing in C...
11/27/2024
ChP Commission Approves Chinese Pharmacopeia 2025
11/26/2024
Snapshot of BMI System Financial Performance in 3Qs/2024
11/25/2024
China's Real-World Data Pilot Drives Global Collaboration and Regulato...
11/25/2024
DP Tech and Lepu Biopharma Enter ADC Partnership
11/25/2024
Rui Thera Present Clinical Trial Results of CD19 CAR NK Cell Therapy i...
Page:
8
/
42
Total number of articles:
1245
:
[First]
[<<]
[6]
[7]
[8]
[9]
[10]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit